Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
S&P Biotech SPDR (NY: XBI)
96.86 USD  -0.23 (-0.24%)
Streaming Delayed Price  /  Updated: 1:12 PM EST, Feb 18, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
S&P Biotech SPDR
Sector
Exchange Traded NY
Net Assets 5.24B
Inception Date
Related Funds
Quote
Price 96.86
Volume 1,406,355
Last Trade Feb 18, 1:12pm
Change (%)
-0.23 (-0.24%)
Prev. Close 97.09
YTD %
+2.30%
Dividend Yield 0.23%
Performance
YTD
+2.18 (2.30%)
1 Month
+2.15 (2.27%)
3 Month
+11.83 (13.91%)
6 Month
+13.47 (16.15%)
1 Year
+11.22 (13.10%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
The Week Ahead In Biotech: Agile, Baudax Bio, Merck and Esperion Await FDA Decisions
Biotech stocks were quiet in the week endingFeb. 14 amid some data readouts at a couple of conferences and earnings news flow from ... Read More
from Benzinga
The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... Read More
from Benzinga
Top News
More News
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
XBI: Large Inflows Detected at ETF
Symbols mentioned in this story: XBI Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded... Read More
from ETF Channel
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight
Biotech stocks recovered last week along with the broader markets, which bounced back from a China coronavirus-induced sell-off. Big ... Read More
from Benzinga
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... Read More
from Benzinga
The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
XBI: ETF Outflow Alert
Symbols mentioned in this story: XBI Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded... Read More
from ETF Channel
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... Read More
from Benzinga
Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates
Biotech stocks have come under some selling pressure in the new year. However, January did witness some strong stock-specific upward ... Read More
from Benzinga
The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus
Biotech stocks see-sawed through the week ended Jan. 31 and ended the month lower overall. Big pharma earnings of the week were mostly ... Read More
from Benzinga
The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.